Regional cerebral opioid receptor studies with [11C]diprenorphine in normal volunteers

The results are described of the cerebral uptake and heterogeneous retention of [11C]diprenorphine after intravenous injection in 4 normal volunteers. This potent opioid antagonist (Kd = 0.2 nM) was chosen because of its safety, lack of side-effects at trace doses in human pilot studies, rapid cerebral uptake and high percentage (80-90%) specific binding in animal in vivo studies. High uptake of [11C]diprenorphine was demonstrated in regions such as the thalamus, caudate nucleus, temporal, frontal and parietal cortices, which are known from postmortem studies to have high concentrations of opioid receptors. A stable level of activity or a very slow decline in activity was observed between 20 and 50 min after injection in areas such as the caudate nucleus and thalamus. Conversely, rapid washout of activity was observed in the occipital cortex, which is known to have low opioid receptor concentrations. Some 80-90% of maximum binding was naloxone reversible. These results with a ligand that is safe and without side-effects, suggest that this technique is suitable for studies of opioid physiology in man.

[1]  J. Palacios,et al.  Multiple opiate receptor in human brain: an autoradiographic investigation. , 1983, Life sciences.

[2]  S. Luthra,et al.  NEW LABELLED LIGAND FOR IN-VIVO STUDIES OF OPIOID PHYSIOLOGY , 1985, The Lancet.

[3]  Dean F. Wong,et al.  Imaging Opiate Receptors in the Human Brain by Positron Tomography , 1985, Journal of computer assisted tomography.

[4]  H. Fields,et al.  Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain , 1979, Nature.

[5]  C. Pert,et al.  In vivo autoradiography: Visualization of stress-induced changes in opiate receptor occupancy in the rat brain , 1984, Brain Research.

[6]  T. Yaksh,et al.  Sites of morphine induced analgesia in the primate brain: relation to pain pathways. , 1974 .

[7]  V. Pike,et al.  The preparation of carbon-11 labelled diprenorphine: a new radioligand for the study of the opiate receptor system in vivo , 1985 .

[8]  L. Watkins,et al.  Organization of endogenous opiate and nonopiate pain control systems. , 1982, Science.

[9]  E. J. Simon,et al.  Distribution of stereospecific binding of the potent narcotic analgesic etorphine in the human brain: predominance in the limbic system. , 1973, Research communications in chemical pathology and pharmacology.

[10]  Solomon H. Snyder,et al.  Autoradiographic localization of the opiate receptor in rat brain , 1975 .

[11]  G. Besser,et al.  INCREASED β-ENDORPHIN BUT NOT MET-ENKEPHALIN LEVELS IN HUMAN CEREBROSPINAL FLUID AFTER ACUPUNCTURE FOR RECURRENT PAIN , 1980, The Lancet.

[12]  H. Morris,et al.  Identification of two related pentapeptides from the brain with potent opiate agonist activity , 1975, Nature.

[13]  E. T. Iwamoto,et al.  Multiple opioid receptors , 1981, Medicinal research reviews.

[14]  W. Sadee,et al.  Discrimination of three types of opioid binding sites in rat brain in vivo. , 1984, Molecular pharmacology.

[15]  W C Eckelman,et al.  S‐[18F]Acetylcyclofoxy: a useful probe for the visualization of opiate receptors in living animals , 1984, FEBS letters.

[16]  A. Goldstein,et al.  Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[17]  W. Sadee,et al.  In vivo receptor binding of opioid drugs at the mu site. , 1985, The Journal of pharmacology and experimental therapeutics.

[18]  J. Langdon.  Computerised axial tomography , 1980, British Dental Journal.

[19]  C. Crouzel,et al.  Preparation of [11C]buprenorphine--a potential radioligand for the study of the opiate receptor system in vivo. , 1987, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[20]  H. Wagner,et al.  3H-diprenorphine is selective for mu opiate receptors in vivo. , 1986, Life sciences.

[21]  S. Snyder,et al.  Properties of opiate-receptor binding in rat brain. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. J. Simon,et al.  Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Mullis,et al.  Opiate antagonist receptor binding in vivo: evidence for a new receptor binding model , 1980, Brain Research.